Long‐term follow‐up of immunogenicity in radiographic axial spondyloarthritis patients: beyond drug survival and tapering. Comment on the article by Clarissa et al

Documenti analoghi

• Insights on axial spondyloarthritis in multicenter cohorts of undiagnosed back pain patients: comment on the article by Maksymowych et al
  di: Qing Long, et al.
  Pubblicazione: (2025)
• Clinical Images: Klippel–Feil syndrome in a patient referred for axial spondyloarthritis
  di: Zeyu Tang, et al.
  Pubblicazione: (2026)
• Refining the interpretation of drug survival and safety in VEXAS syndrome: the importance of competing risks and exposure time. Comment on the article by Eviatar et al
  di: Yi Pei, et al.
  Pubblicazione: (2026)
• The oral microbiota in persons at risk for rheumatoid arthritis: follow‐up data for the article by Kroese et al
  di: Johanna M. Kroese, et al.
  Pubblicazione: (2025)
• Potential Confounding by Weight Loss: Comment on the article by Jorge et al.
  di: Eylul Kizkapan, et al.
  Pubblicazione: (2026)